Related Experiment Video
Updated: May 21, 2026
09:57
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Percutaneous mitral valvuloplasty using echocardiographic intercommissural diameter as reference for balloon sizing:
Hamid Reza Sanati1, Ali Zahedmehr, Farshad Shakerian
1Cardiovascular Intervention Research Center, Rajaei Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Clinical Cardiology
|June 8, 2012
Summary
A new echocardiographic method for sizing balloons during percutaneous mitral valvuloplasty safely and effectively improves outcomes. This technique reduces mitral regurgitation and increases mitral valve area compared to traditional sizing.
Area of Science:
- Cardiology
- Interventional Cardiology
- Echocardiography
Background:
- Percutaneous balloon mitral valvuloplasty (PBMR) is standard for mitral stenosis.
- PBMR has limitations in certain patient groups.
- Optimizing balloon sizing is crucial for procedural success.
Purpose of the Study:
- To evaluate a novel echocardiographic method for balloon sizing in PBMR.
- To compare outcomes of echocardiographic-based sizing versus height-based reference sizing.
- To determine if echocardiographic sizing improves mitral valve area and reduces mitral regurgitation.
Main Methods:
- Eighty-six patients with mitral stenosis were randomized.
- Group 1: Height-based balloon reference sizing (HBRS).
- Group 2: Echocardiographic measurement of intercommissural diameter for balloon sizing (EBRS).
- Outcomes assessed: Mitral valve area (MVA) and mitral regurgitation (MR) severity.
- Statistical analysis using an intention-to-treat approach.
Main Results:
- EBRS group used smaller balloons (24.5 mm) than HBRS group (26.4 mm).
- EBRS resulted in significantly larger final MVAs (1.5 cm² vs 1.4 cm²).
- New or aggravated MR was significantly lower in the EBRS group (11.5% vs 29.3%).
Conclusions:
- Echocardiographic measurement of intercommissural diameter for balloon sizing is safe and effective.
- This method leads to improved MVA and reduced iatrogenic mitral regurgitation.
- The Inoue technique with echocardiographic sizing offers better outcomes in PBMR.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...